Powered By
Continue with Facebook
Continue with Email
If you’ve been diagnosed with hormone receptor-positive breast cancer, there’s a good chance your doctor has mentioned tamoxifen or anastrozole. These two hormonal therapies are among the most commonly prescribed treatments for reducing the risk of breast cancer recurrence.
Both medications are effective, but they work differently and have different benefits, risks, and side effect profiles. That can make the decision feel complicated.
The good news is that studies show both medications are highly effective for many women with hormone-sensitive breast cancer. The “right” option often depends on factors like whether you’ve gone through menopause, your bone health, your risk of blood clots, and how well you tolerate side effects.
In this guide, we’ll compare tamoxifen versus anastrozole, including how they work, how effective they are, and what side effects to expect. The goal isn’t to choose a winner. It’s to help you feel more informed so you can have better conversations with your cancer care team.
Tamoxifen (Soltamox) and anastrozole (Arimidex) are both endocrine therapies, also called hormone therapies. They’re used to treat hormone receptor-positive breast cancer, meaning the cancer grows in response to estrogen or progesterone. Hormone therapies lower the chance that estrogen will help cancer cells grow or return.
Tamoxifen belongs to a class of drugs called selective estrogen receptor modulators, or SERMs. It works by blocking estrogen receptors on breast cancer cells. In other words, it prevents estrogen from “unlocking” cancer cell growth in breast tissue.
Tamoxifen has been used for decades and is approved for both premenopausal and postmenopausal women. It’s often prescribed for:
Unlike aromatase inhibitors, tamoxifen doesn't require menopause to work.
Anastrozole is an aromatase inhibitor. Instead of blocking estrogen receptors, it lowers the body’s estrogen levels by stopping an enzyme called aromatase from converting other hormones into estrogen.
Because the ovaries still produce significant amounts of estrogen before menopause, anastrozole is generally used only in postmenopausal women or in premenopausal women receiving ovarian suppression therapy to medically induce menopause.
That’s one of the biggest differences between tamoxifen and anastrozole.
For many women, both drugs are highly effective at lowering the risk of breast cancer recurrence.
Anastrozole Might Be Slightly More Effective for Preventing Cancer Recurrence Studies have compared tamoxifen and anastrozole in people with hormone receptor-positive breast cancer. In women who have gone through menopause, drugs like anastrozole may work a little better at lowering the chance that cancer will come back, especially during the first few years after treatment.
But newer research shows that, for many people, the two drugs may not make a big difference in how long they live, especially over the long term. One recent study found that in some groups, the difference in how well the drugs worked was small. Because of this, side effects and quality of life are very important when choosing treatments.
Different Side Effects But Same Effect on Quality of Life Another study looked at women treated for hormone-sensitive DCIS who took either anastrozole or tamoxifen. It found that the overall quality of life was about the same with both drugs, although the side effects were different.
Women taking tamoxifen were more likely to have hot flashes and gynecologic symptoms. Women taking anastrozole were more likely to have joint pain and vaginal symptoms. These findings show that choosing between tamoxifen and anastrozole isn’t only about which drug works better. It’s also about which side effects and health risks matter most to you.
Does One Drug Work Better Before Menopause? Usually, tamoxifen is preferred for premenopausal women unless ovarian suppression is added. That’s because aromatase inhibitors like anastrozole don’t work effectively if the ovaries are still producing estrogen normally.
In higher-risk premenopausal breast cancer, studies have shown that ovarian suppression plus an aromatase inhibitor may reduce recurrence risk slightly more than tamoxifen alone, although side effects can also be more intense.
Hormone therapies can cause symptoms similar to menopause because they affect how estrogen works in the body. Shared side effects may include:
Still, the anastrozole vs. tamoxifen side effects profile isn’t identical. Each drug has some unique risks.
Tamoxifen Side Effects Tamoxifen is associated with several serious side effects, including increased risks of:
These risks are relatively uncommon, but they matter, especially for women with a history of clotting disorders or stroke risk factors.
Tamoxifen can also sometimes help preserve bone density in postmenopausal women, which may be an advantage for women already at risk for osteoporosis.
Who May Need Caution With Tamoxifen? Tamoxifen may not be the best fit for women with:
Anastrozole Side Effects Because anastrozole dramatically lowers estrogen levels, it’s strongly associated with bone loss and joint pain. Common side effects include:
In one study, women taking anastrozole reported significantly more musculoskeletal pain and vaginal symptoms than women taking tamoxifen. The study also noted that younger postmenopausal women experienced more severe vaginal symptoms and weight concerns overall.
Aromatase inhibitors can weaken bones over time because estrogen helps maintain bone density. That’s why women taking anastrozole often need bone density monitoring and may be advised to take calcium, vitamin D, or bone-strengthening medications.
Does Anastrozole Work Before Menopause? Yes, in most cases. Anastrozole only works effectively when ovarian production has stopped or been medically suppressed.
For premenopausal women, this may mean using medications or surgery to suppress ovarian function. Drug-induced menopause can intensify symptoms and affect bone health.
Who May Need Caution With Anastrozole? Anastrozole may not be ideal for women with:
Doctors don’t usually choose tamoxifen or anastrozole randomly. Recommendations are often personalized based on your medical history and life stage.
In some cases, women switch from one medication to another during treatment because of side effects or changing health needs. That’s common and doesn’t mean treatment has “failed.”
When comparing tamoxifen versus anastrozole, effectiveness is only part of the conversation.
Research shows that long-term quality of life significantly affects whether women stay on therapy consistently. A quality-of-life analysis in The Lancet found that while overall mental and physical health scores were similar between the two drugs, symptom patterns differed enough to influence the participants’ preferences.
That’s important because hormone therapy is often taken for five years or longer. A medication only works if you can realistically continue taking it.
Choosing between tamoxifen and anastrozole isn’t about finding the “better” drug. It’s about finding the best fit for your body, medical history, and priorities.
Your oncologist’s role is to explain the potential benefits, side effects, and long-term risks. Your role is to share what matters most to you, whether that’s reducing recurrence risk as much as possible, protecting bone health, minimizing hot flashes, or maintaining quality of life.
Shared decision-making can help ensure your treatment plan reflects both medical evidence and your personal goals.
If one medication doesn’t feel manageable, it’s OK to revisit the conversation. Breast cancer treatment is highly personal, and hormone therapy can often be adjusted over time.
On MyBCTeam, people share their experiences with breast cancer, get advice, and find support from others who understand.
Have you taken anastrozole or tamoxifen? What matters the most to you when selecting a treatment option? Let others know in the comments below.
Get updates directly to your inbox.
Continue with Facebook
Continue with Email
Continue with Facebook
Continue with Email
Become a member to get even more
Join
Your Privacy Choices
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.